Clinical Trials Browser

Phase 2 × ulixertinib × 30 days × Clear all

NCT03417739 2026-02-25

A Phase II Study of BVD-523 in Metastatic Uveal Melanoma

Phase 2 Terminated

13 enrolled 9 charts

Uveal Melanoma